Patents by Inventor Mark Walter Frohlich

Mark Walter Frohlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS T CELL IMMUNOTHERAPY
    Publication number: 20240016844
    Abstract: Methods of treating cancer with a precision genome engineered NeoTCR Product are described herein.
    Type: Application
    Filed: June 9, 2023
    Publication date: January 18, 2024
    Applicant: PACT PHARMA, INC.
    Inventors: Barbara Sennino, Bhamini Purandare, Stefanie Mandl-Cashman, Gregg D. Fine, Arati V. Rao, Todd Stallings-Schmitt, Mark Walter Frohlich, Alex Franzusoff
  • METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS T CELL IMMUNOTHERAPY
    Publication number: 20210205363
    Abstract: Methods of treating cancer with a precision genome engineered NeoTCR Product are described herein.
    Type: Application
    Filed: November 16, 2020
    Publication date: July 8, 2021
    Applicant: PACT PHARMA, INC.
    Inventors: Barbara Sennino, Bhamini Purandare, Stefanie Mandl-Cashman, Gregg D. Fine, Arati V. Rao, Todd Stallings-Schmitt, Mark Walter Frohlich, Alex Franzusoff